Project Details
| Status | Active |
|---|---|
| Effective start/end date | 3/03/26 → 31/12/27 |
Clinical Trial Phase
- Phase III (a & b)
- External Sponsor
CLEOPATTRA: Effects of NNC6019-0001 versus placebo on cardiovascular outcomes in participants with transthyretin amyloid cardiomyopathy (ATTR-CM)
- Rao, Sriram (Primary Chief Investigator (PCI))
Project: Research